ForDoz Pharma Corp Revenue and Competitors

East windsor, NJ

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • ForDoz Pharma Corp's estimated annual revenue is currently $8.2M per year.(i)
  • ForDoz Pharma Corp's estimated revenue per employee is $201,000

Employee Data

  • ForDoz Pharma Corp has 41 Employees.(i)
  • ForDoz Pharma Corp grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M25-11%N/AN/A
#2
$35.8M1788%N/AN/A
#3
$5.4M27-25%N/AN/A
#4
$4180M145161%$550MN/A
#5
$12.5M6215%N/AN/A
#6
$6.7M119-37%$199.6MN/A
#7
$9.4M477%N/AN/A
#8
$10.3M516%N/AN/A
#9
$106.3M52916%N/AN/A
#10
$15.5M7720%N/AN/A
Add Company

What Is ForDoz Pharma Corp?

ForDoz Pharma Co. is a privately-owned specialty pharmaceutical company focusing on development, manufacturing, and commercialization of value-added sterile complex injectable products. At our facility in East Windsor, NJ, we established our R&D labs, cGMP QC labs and cGMP microbiology labs. We successfully constructed, qualified and validated a sterile complex product manufacturing facility which complies with both US and EU cGMP standards. we commercialize our products via a closed loop system, from R&D, analytical testing, process scale-up to manufacturing the commercial product in one campus. Technology Platform We established proprietary particle-based drug delivery technology platforms, which enable us to develop and manufacture superior products with high technology barrier that improve patient care. We are specialized in the development of nano-particle drugs including liposomes, micelles and nano-crystals; submicron-particle drugs including emulsion, submicron crystals and suspensions; and micron-particle drugs such as microspheres. Manufacturing Facility We have made substantial investment and efforts to construct the leading manufacturing facility specifically for sterile complex formulation with state-of-the-art manufacturing equipment, a well-experienced manufacturing team and well-established quality system to ensure our product can be manufactured and delivered to patients safely with highest quality. CDMO Business We have huge advantage for CDMO business of complex injectable products. We have very strong R&D, quality and manufacturing team with more than 20 years’ experience and successful track record. Our sterile manufacturing facility can process both liquid and lyophilized product, including cytotoxic products. We provide our clients with rapid complex injectable product development from early stage to final production. We are looking for talents to join our team in using cutting-edge technology to make high-quality complex drug products.

keywords:N/A

N/A

Total Funding

41

Number of Employees

$8.2M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10M438%N/A
#2
$13.9M570%N/A
#3
$18.4M580%N/A
#4
$6.3M58-13%N/A
#5
$7.1M612%N/A